Prague Med. Rep. 2016, 117, 90-97
https://doi.org/10.14712/23362936.2016.9
CCL5 rs2107538 Polymorphism Increased the Risk of Tuberculosis in a Sample of Iranian Population
References
1. 2013) A genetic association study of CCL5 –28 C>G (rs2280788) polymorphism with risk of tuberculosis: a meta-analysis. PLoS One 8(12), e83422.
< , M. A., Mandal, R. K., Haque, S., Panda, A. K., Akhter, N., Ali, A. (https://doi.org/10.1371/journal.pone.0083422>
<PubMed>
2. 2012) Association of IRGM polymorphisms and susceptibility to pulmonary tuberculosis in Zahedan, Southeast Iran. ScientificWorldJournal 2012, 950801.
, G., Hashemi, M., Taheri, M., Naderi, M., Eskandari-Nasab, E., Atabaki, M. (
3. 2011) Polymorphisms in the RANTES gene increase susceptibility to active tuberculosis in Tunisia. DNA Cell Biol. 30(10), 789–800.
< , W., Harizi, H., Bougmiza, I., Ben Kahla, I., Letaief, M., Boukadida, J. (https://doi.org/10.1089/dna.2010.1200>
4. 2014) CCL3L1 copy number, CCR5 genotype and susceptibility to tuberculosis. BMC Med. Genet. 15, 5.
< , D., Taype, C., Goulding, J., Levin, M., Eley, B., Anderson, S., Shaw, M. A., Armour, J. A. (https://doi.org/10.1186/1471-2350-15-5>
<PubMed>
5. 2007) Association between RANTES functional polymorphisms and tuberculosis in Hong Kong Chinese. Genes Immun. 8(6), 475–479.
< , S. F., Tam, C. M., Wong, H. S., Kam, K. M., Lau, Y. L., Chiang, A. K. (https://doi.org/10.1038/sj.gene.6364412>
6. 2013) Host genomics and control of tuberculosis infection. Public Health Genomics 16(1–2), 44–49.
< , A., Orlova, M., Barrera, L. F., Schurr, E. (https://doi.org/10.1159/000341499>
7. 2014) Evaluation of CCL5 –403 G>A and CCR5 Δ32 gene polymorphisms in patients with breast cancer. Cancer Biomark. 14(5), 343–351.
< , E., Hashemi, M., Ebrahimi, M., Amininia, S., Bahari, G., Mashhadi, M. A., Taheri, M. (https://doi.org/10.3233/CBM-140411>
8. 2012) CCR5 gene polymorphism is a genetic risk factor for radiographic severity of rheumatoid arthritis. Tissue Antigens 80(5), 416–423.
< , S. W., Sa, K. H., Kim, S. I., Lee, S. I., Park, Y. W., Lee, S. S., Yoo, W. H., Soe, J. S., Nam, E. J., Lee, J., Park, J. Y., Kang, Y. M. (https://doi.org/10.1111/j.1399-0039.2012.01955.x>
9. 2013a) Association of CTSZ rs34069356 and MC3R rs6127698 gene polymorphisms with pulmonary tuberculosis. Int. J. Tuberc. Lung Dis. 17(9), 1224–1228.
< , M., Eskandari-Nasab, E., Moazeni-Roodi, A., Naderi, M., Sharifi-Mood, B., Taheri, M. (https://doi.org/10.5588/ijtld.12.0762>
10. 2013b) Association of adiponectin rs1501299 and rs266729 gene polymorphisms with nonalcoholic fatty liver disease. Hepat. Mon. 13(5), e9527.
< , M., Hanafi Bojd, H., Eskandari-Nasab, E., Bahari, A., Hashemzehi, N. A., Shafieipour, S., Narouie, B., Taheri, M., Ghavami, S. (https://doi.org/10.5812/hepatmon.9527>
<PubMed>
11. 2015) Macrophage migration inhibitory factor –173 G/C polymorphism is associated with an increased risk of pulmonary tuberculosis in Zahedan, Southeast Iran. EXCLI J. 14, 117–122.
, M., Sharifi-Mood, B., Rasouli, A., Amininia, S., Naderi, M., Taheri, M. (
12. 2012) R620W functional polymorphism of protein tyrosine phosphatase non-receptor type 22 is not associated with pulmonary tuberculosis in Zahedan, southeast Iran. Genet. Mol. Res. 11(2), 1075–1081.
< , H. R., Hashemi, M., Hashemi, S. A., Moazeni-Roodi, A., Naderi, M., Sharifi-Mood, B., Taheri, M., Mohammadi, M., Ghavami, S. (https://doi.org/10.4238/2012.April.27.6>
13. 2011) Influence of variations in CCL3L1 and CCR5 on tuberculosis in a northwestern Colombian population. J. Infect. Dis. 203(11), 1590–1594.
< , M., Mummidi, S., Ramsuran, V., Pham, M. H., Maldonado, R., Begum, K., Valera, M. S., Sanchez, R., Castiblanco, J., Kulkarni, H., Ndung’u, T., He, W., Anaya, J. M., Ahuja, S. K. (https://doi.org/10.1093/infdis/jir145>
<PubMed>
14. 2008) Expression and regulation of chemokines in mycobacterial infection. J. Infect. 57(5), 374–384.
< , P. (https://doi.org/10.1016/j.jinf.2008.08.010>
15. 2013) Association of IL-10 and CCL5 single nucleotide polymorphisms with tuberculosis in the Sudanese population. Trop. Med. Int. Health 18(9), 1119–1127.
< , N., Fahal, A., van de Sande, W. J. (https://doi.org/10.1111/tmi.12141>
16. 2013) Factors that influence current tuberculosis epidemiology. Eur. Spine J. 22, 539–548 (Suppl. 4).
< , J. P., Moreno, A., Fina, L., del Bano, L., Orcau, A., de Olalla, P. G., Cayla, J. A. (https://doi.org/10.1007/s00586-012-2334-8>
<PubMed>
17. 2012) Genetic polymorphisms of CCL2, CCL5, CCR2 and CCR5 genes in Sahariya tribe of North Central India: an association study with pulmonary tuberculosis. Infect. Genet. Evol. 12(5), 1120–1127.
< , G., Poojary, S. S., Raj, P., Tiwari, P. K. (https://doi.org/10.1016/j.meegid.2012.03.018>
18. 2010) Current findings, challenges and novel approaches in human genetic susceptibility to tuberculosis. Tuberculosis (Edinb.) 90(2), 71–83.
< , M., Hoal, E. G. (https://doi.org/10.1016/j.tube.2010.02.002>
19. 2014a) TIRAP rs8177374 gene polymorphism increased the risk of pulmonary tuberculosis in Zahedan, southeast Iran. Asian Pac. J. Trop. Med. 7(6), 451–455.
< , M., Hashemi, M., Pourmontaseri, Z., Eskandari-Nasab, E., Bahari, G., Taheri, M. (https://doi.org/10.1016/S1995-7645(14)60073-0>
20. 2014b) CD209 promoter –336 A/G (rs4804803) polymorphism is associated with susceptibility to pulmonary tuberculosis in Zahedan, southeast Iran. J. Microbiol. Immunol. Infect. 47(3), 171–175.
< , M., Hashemi, M., Taheri, M., Pesarakli, H., Eskandari-Nasab, E., Bahari, G. (https://doi.org/10.1016/j.jmii.2013.03.013>
21. 2009) Polymorphisms in CCL5 promoter are associated with pulmonary tuberculosis in northern Spain. Int. J. Tuberc. Lung Dis. 13(4), 480–485.
, M., Baquero, I. C., Sánchez-Velasco, P., Fariñas, M. C., Ausín, F., Leyva-Cobián, F., Ocejo-Vinyals, J. G. (
22. 2011) CCL5 (RANTES) gene polymorphisms in pulmonary tuberculosis patients of south India. Int. J. Immunogenet. 38(5), 397–402.
< , P., Alagarasu, K., Singh, B., Afsal, K. (https://doi.org/10.1111/j.1744-313X.2011.01021.x>